International research with its roots in Auckland has produced a breakthrough that could yield a new type of drug treatment for tuberculosis.
The experiments on tropical zebrafish found that granulomas - lumps caused by TB bacteria - create their own network of blood vessels in a process called angio-genesis. This also occurs in tumours and the researchers tested - in zebrafish larvae - expensive, biological medications that disrupt human cancers' blood-vessel-forming mechanisms.
The drug treatment reduced the infection burden and limited the spread of TB within the fish larvae, say the researchers, whose paper is published today in Nature, the world's top scientific journal.
They say this opens a new line of research for others to find inexpensive drugs targeting blood vessel formation in granulomas.
One of the scientists, Professor Philip Crosier, of Auckland University, said it would be unrealistic to use costly cancer drugs for the widespread treatment of TB.